Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Luke

Showing results (51-60 of 422) with videos related to

Pageof 43
Sort By:
Synlett : Accounts and Rapid Communications in Synthetic Organic Chemistry|April 30, 2021
Facile Pyridine S <sub></sub> Ar Reactions via <i>N</i>-Phosphonium-Pyridinium IntermediatesBenjamin T Boyle, J Luke Koniarczyk, Andrew McNally
Journal of Visualized Experiments : Jove|April 25, 2012
Phenotypic and functional characterization of endothelial colony forming cells derived from human umbilical cord bloodNutan Prasain, J Luke Meador, Mervin C Yoder
Royal Society Open Science|August 5, 2024
Managing disclosure outcomes in intelligence interviewsDavid A Neequaye, Timothy J Luke, Kristina Kollback
Journal for Immunotherapy of Cancer|February 15, 2026
Unlocking the promise of innate biology through the HLA-G/ILT2/ILT4 pathwayCourtney Beers, Robert L Ilaria, Jason J Luke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2020
PD-1 Blockade in Chinese versus Western Patients with MelanomaAlexander N Shoushtari, Riyue Bao, Jason J Luke
AMA Journal of Ethics|September 1, 2025
How Should Clinical Teams Integrate Findings From Social Needs Screenings Into Children's Care Plans?Stephanie G Menko, Michael J Luke, Aditi Vasan
Journal for Immunotherapy of Cancer|February 7, 2023
Targeting Cbl-b in cancer immunotherapyRyan C Augustin, Riyue Bao, Jason J Luke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2018
Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon AxisBrian W Labadie, Riyue Bao, Jason J Luke
Frontiers in Oncology|June 28, 2021
Therapeutic Advancements Across Clinical Stages in Melanoma, With a Focus on Targeted ImmunotherapyClaudia Trojaniello, Jason J Luke, Paolo A Ascierto
Journal of the International Society of Sports Nutrition|April 5, 2012
Effect of betaine supplementation on cycling sprint performanceJ Luke Pryor, Stuart As Craig, Thomas Swensen
Pageof 43

Showing results (51-60 of 422) with videos related to

Sort By:
Pageof 43
Synlett : Accounts and Rapid Communications in Synthetic Organic Chemistry|April 30, 2021
Facile Pyridine S <sub></sub> Ar Reactions via <i>N</i>-Phosphonium-Pyridinium IntermediatesBenjamin T Boyle, J Luke Koniarczyk, Andrew McNally
Journal of Visualized Experiments : Jove|April 25, 2012
Phenotypic and functional characterization of endothelial colony forming cells derived from human umbilical cord bloodNutan Prasain, J Luke Meador, Mervin C Yoder
Royal Society Open Science|August 5, 2024
Managing disclosure outcomes in intelligence interviewsDavid A Neequaye, Timothy J Luke, Kristina Kollback
Journal for Immunotherapy of Cancer|February 15, 2026
Unlocking the promise of innate biology through the HLA-G/ILT2/ILT4 pathwayCourtney Beers, Robert L Ilaria, Jason J Luke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2020
PD-1 Blockade in Chinese versus Western Patients with MelanomaAlexander N Shoushtari, Riyue Bao, Jason J Luke
AMA Journal of Ethics|September 1, 2025
How Should Clinical Teams Integrate Findings From Social Needs Screenings Into Children's Care Plans?Stephanie G Menko, Michael J Luke, Aditi Vasan
Journal for Immunotherapy of Cancer|February 7, 2023
Targeting Cbl-b in cancer immunotherapyRyan C Augustin, Riyue Bao, Jason J Luke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2018
Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon AxisBrian W Labadie, Riyue Bao, Jason J Luke
Frontiers in Oncology|June 28, 2021
Therapeutic Advancements Across Clinical Stages in Melanoma, With a Focus on Targeted ImmunotherapyClaudia Trojaniello, Jason J Luke, Paolo A Ascierto
Journal of the International Society of Sports Nutrition|April 5, 2012
Effect of betaine supplementation on cycling sprint performanceJ Luke Pryor, Stuart As Craig, Thomas Swensen
Pageof 43